Allied Biotech Corporation (TPEX:1780)

Allied Biotech Revenue

Allied Biotech had revenue of 240.25M TWD in the quarter ending March 31, 2026, with 14.57% growth. This brings the company's revenue in the last twelve months to 880.06M, up 12.44% year-over-year. In the year 2025, Allied Biotech had annual revenue of 849.51M with 5.28% growth.

• Revenue (ttm): 880.06M
• Revenue Growth: +12.44%
• P/S Ratio: 2.70
• Revenue / Employee: 22.00M
• Employees: 40
• Market Cap: 2.38B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	849.51M	42.59M	5.28%
Dec 31, 2024	806.92M	86.49M	12.00%
Dec 31, 2023	720.43M	3.69M	0.51%
Dec 31, 2022	716.75M	39.99M	5.91%
Dec 31, 2021	676.76M	58.69M	9.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error